PD-L1 inhibitor Clinical Trials
2 recruitingDrug
Phase 21
Showing 1–2 of 2 trials
Recruiting
Phase 2
HAIC Combined With Immune Therapy for Advanced, Non-Resectable ICC
Advanced CancerICC
Eastern Hepatobiliary Surgery Hospital50 enrolled1 locationNCT07364305
Recruiting
Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Peking University Cancer Hospital & Institute65 enrolled1 locationNCT06869239